 EMERYVILLE, Calif.--BUSINESS WIRE--Adamas Pharmaceuticals, Inc. Nasdaq: ADMS today announced that the compensation committee of the companys board of directors granted eight new employees restricted stock units to acquire 106,500 shares of the companys common stock. The restricted stock units vest over three years and were granted pursuant to the Adamas Pharmaceuticals, Inc. 2016 Inducement Plan, which was approved by the companys board of directors in March 2016 under Rule 5653c4 of 